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Abstract 
Background: The World Health Organization recommends malaria to be confirmed by either microscopy or a rapid 
diagnostic test (RDT) before treatment. The correct use of RDTs in resource-limited settings facilitates basing treat-
ment onto a confirmed diagnosis; contributes to speeding up considering a correct alternative diagnosis, and pre-
vents overprescription of anti-malarial drugs, reduces costs and avoids unnecessary exposure to adverse drug effects. 
This review aims to evaluate health workers’ compliance to RDT results and factors contributing to compliance.
Methods: A PROSPERO-registered systematic review was conducted to evaluate health workers’ compliance to RDTs 
in sub-Saharan Africa, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guide-
lines. Studies published up to November 2015 were searched without language restrictions in Medline/Ovid, Embase, 
Cochrane Central Register of Controlled Trials, Web of Science, LILACS, Biosis Previews and the African Index Medicus. 
The primary outcome was health workers treating patients according to the RDT results obtained.
Results: The literature search identified 474 reports; 14 studies were eligible and included in the quantitative analysis. 
From the meta-analysis, health workers’ overall compliance in terms of initiating treatment or not in accordance with 
the respective RDT results was 83 % (95 % CI 80–86 %). Compliance to positive and negative results was 97 % (95 % CI 
94–99 %) and 78 % (95 % CI 66–89 %), respectively. Community health workers had higher compliance rates to nega-
tive test results than clinicians. Patient expectations, work experience, scepticism of results, health workers’ cadres and 
perceived effectiveness of the test, influenced compliance.
Conclusions: With regard to published data, compliance to RDT appears to be generally fair in sub-Saharan Africa; 
compliance to negative results will need to improve to prevent mismanagement of patients and overprescribing of 
anti-malarial drugs. Improving diagnostic capacity for other febrile illnesses and developing local evidence-based 
guidelines may help improve compliance and management of negative RDT results.
Trial registration: CRD42015016151 (PROSPERO)
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Background
Plasmodium falciparum malaria is estimated to have 
caused 528,000 deaths and 163 million clinical epi-
sodes in sub-Saharan Africa in 2013 [1]. Early diagno-
sis and treatment with appropriate anti-malarial drugs 
can prevent severe illness and lethal outcome [2, 3]. 
Artemisinin-based combination therapy (ACT) is cur-
rently recommended for the treatment of uncomplicated 
malaria caused by P. falciparum [3, 4] and is increasingly 
used for non-falciparum malaria [5]. Effective case-man-
agement of malaria consists of an efficacious treatment, 
prompt access to treatment and diagnosis, provider com-
pliance to treatment guidelines, and patient adherence to 
medication [3, 6] (Fig. 1).
Presumptive diagnosis and treatment of malaria based 
on symptoms leads to over- diagnosis of malaria and 
missed diagnosis for patients without malaria [7, 8]. 
The World Health Organization (WHO) recommends 
that any suspected malaria case in any epidemiological 
setting should be parasitologically-confirmed by either 
microscopy or rapid diagnostic test (RDT) before treat-
ment [3]. Lack of trained personnel, equipment [9], and 
reagents for microscopy in most remote rural areas in 
Africa [10, 11] with high malaria burden makes the RDT 
the most practically suitable tool to confirm a malaria 
diagnosis [12, 13]. RDTs are immunochromatographic 
test kits which confirm the presence of malaria para-
sites in suspected patients by detecting one or a com-
bination of the following three Plasmodium antigens: 
Plasmodium histidine-rich protein (HRP) 2 (pHRP-2) 
for P. falciparum or a ‘pan-specific’ aldolase to detect 
other species, such as P. vivax or Plasmodium lactate 
dehydrogenase (LDH) variants (pLDH) (with clonal-
ity specific to the various Plasmodium species infecting 
humans) [14, 15].
The use of malaria RDT can reduce over-prescribing 
of anti-malarial drugs (AMD). Studies have shown that 
in most endemic countries in sub-Saharan Africa, health 
workers of different cadres do not comply with malaria 
RDTs; they prescribe AMDs to patients with RDT 
negative results [13, 16–18]. This has implications on 
resources for patient, family members and health system 
since some drug combinations are relatively expensive 
[19–21]. Non-compliance to malaria negative results by 
prescribing AMDs neglects underlying cause of fever and 
expose patients unnecessarily to adverse effects; underly-
ing infections, such as sepsis, pneumonia and meningitis 
[22–25], present as malaria clinically but are not rou-
tinely investigated [26] and may not be treated [10, 27].
To treat malaria effectively, to reduce costs and avoid 
unnecessary exposure to drug adverse effects, there is 
a need to correctly diagnose and comply with malaria 
treatment guidelines or clinical decision algorithms. 
Health workers (HWs) need to use the correct treatment 
based on the RDT results.
This systematic review examines data available on HWs 
compliance to RDT results in sub-Saharan Africa, and 
investigates factors associated with compliance to results 
(HW treating patients according to the RDT result). The 
primary outcome is the percentage of HWs compliant to 
overall, positive or negative, test results.
Methods
This systematic review was registered in advance in the 
International prospective register of systematic reviews 
(PROSPERO; registration number CRD42015016151) 
which included pre-specified the objectives and inclusion 
criteria [28].
An experienced information specialist (RS) conducted 
a search without language or time restrictions in the 
online electronic databases Ovid Medline, Ovid Embase, 
Cochrane Central Register of Controlled Trials, CINAHL 
Plus with Full Text, African Index Medicus, and African 
Journals Online (AJOL). The search used both free text 
words and medical subject headings for ‘malaria’, ‘RDT’, 
‘health worker’ and ‘compliance’. The search was con-
ducted on 3 March 2015 and updated on 12 November 
2015. Studies reporting on malaria suspected patients of 
any age presenting to HWs of any cadre in sub-Saharan 
Africa were searched. The intervention was the use of a 
WHO recommended RDT kit for parasitological con-
firmation of a malaria diagnosis (a list of WHO recom-
mended RDTs is available online [29]).
Bibliographies of relevant studies retrieved from the 
studies were checked for additional publications. The 
search strategy is described in Additional file  1. End-
Note X7.4 (Thomson Reuters) was used to manage, de-









Fig. 1 Pathway of health systems effectiveness of malaria diagnosis 
and treatment. (Adapted from MalERA consultative group) [6]
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inclusion criteria were: studies were conducted in sub-
Saharan Africa; RDTs were used to diagnose malaria in 
symptomatic patients; the RDTs used were WHO-rec-
ommended; absolute numbers of RDT result adherence 
as primary or secondary outcome were reported. Exclu-
sion criteria were: studies using RDT for active case find-
ing and population screening; conference abstracts; no 
absolute numbers were reported; studies outside sub-
Saharan Africa. Eligibility assessment of studies was per-
formed independently in a blinded, standardized way 
by two reviewers (ANK and BJV). Titles and abstracts 
were screened first, and the two reviewers screened and 
selected relevant full-text articles. ANK extracted quan-
titative data based on the pre-specified criteria into an 
excel sheet (Additional file  2); factors associated with 
compliance were also extracted into the same sheet. All 
the quantitative data was independently checked by BJV. 
Data extracted included author name, year of publica-
tion, place of study, transmission setting, type of RDT, 
cadre and number of HW, age of patients, number of test 
results, RDT positives treated and RDT negatives not 
treated. Both qualitative and quantitative factors were 
also extracted from included studies which reported 
them. The risk of bias of studies was not assessed because 
of the diversity of the study designs included.
The primary outcome measure was proportions in 
percentage of RDT results with appropriate AMD pre-
scription disaggregated to positive and negative results 
adherence. Appropriate treatment was defined as AMDs 
prescribed to RDT positive and AMD not prescribed to 
RDT negative patients (Fig. 2). Formulae for these calcu-
lations are included in Additional file  3. STATA version 
13 (StataCorp, College Station, TX, USA) was used to 
calculate the pooled estimate of proportions appropri-
ately treated overall and negative and positive compli-
ance using random effects. Random effects analysis was 
used after an initial fixed effect analysis had I2 above 
50  %, suggesting heterogeneity. Pooled estimates were 
also stratified by health personnel cadre, age of patients 
and malaria transmission setting. A qualitative synthesis 
of factors contributing to compliance was also reported 
for the included studies.
Results
Study selection
The total number of articles after removing duplicates 
was 474 (Fig.  3). After screening title and abstracts for 
eligibility, 75 full-text articles were examined for eligibil-
ity; 14 studies were included in the quantitative analysis 
[7, 16–18, 30–39]. Five of the studies reported on fac-
tors associated with compliance to RDT results and were 
included in the summary of associated factors [7, 17, 30, 
31, 36].
There were five study designs (Table  1): one rand-
omized control trial [31], four observational [32–34, 38], 
four cross-sectional [17, 18, 36, 37], four cluster ran-
domized trials [7, 16, 30, 35] and pre-post intervention 
study [39]. RDT adherence was a secondary outcome in 
five out of the 14 studies [17, 31, 35, 37, 39].
Health workers’ compliance to malaria results
A pooled meta-analysis using random effects (Fig. 4) for 
the 14 studies [7, 16–18, 30, 31, 33–40] shows an over-
all compliance of 83 % (95 % CI 80–86 %); I2 =  99.9 %, 
Fig. 2 Patient pathway for malaria diagnosis and treatment. The 
shaded areas represent appropriate management (RDT rapid diagnos-
tic test, AMD anti-malarial drug) Fig. 3 Study selection flow (PRISMA)
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Z  =  54.35, p  <  0.001. Appropriate malaria treatment 
based on RDT results (Table 2) was as low as 39.7 % in a 
Zambian study [38] to as high as 99.9 % in Zanzibar [18]. 
The pooled meta-analysis result using random effects for 
RDT positives prescribed AMDs (Fig. 5) was 97 % (95 % 
CI 94–99 %); I2 = 99.2 %, Z = 37.31, p < 0.001. The pro-
portion of positive RDT results prescribed AMDs ranged 
from 72.1 to 100 %. 12 studies reported appropriate pre-
scription of AMDs to RDT positive patients above 93 %; 
six of these studies had 100 % RDT positive compliance 
(Table 2).
Pooled meta-analysis using random effects for RDT 
negative patients not prescribed AMDs (Fig. 6) was 78 % 
(95 % CI 66–89 %); I2 = 99.8 %, Z = 14.60, p < 0.001. The 
proportion of RDT negative patients appropriately not 
prescribed and AMD was between 19.0–99.9 % (Table 2). 
Five studies [16, 31, 36–38] reported less than 60 % com-
pliance to RDT negative results.
Community health workers (CHWs) had the high-
est adherence to negative results (Fig. 6) with a random 
effects pooled proportion of 95  % (95  % CI 92–98  %); 
I2 = 86.4 %, Z = 23.26, p < 0.001 than clinicians with a 
pooled proportion of 75 % (95 % CI 58–89 %); I2 = 99.8 %, 
Z = 11.30, p < 0.001. There were no differences in com-
pliance when stratified by patient age or transmission set-
ting in pooled meta-analyses.
Compliance factors
Six out of the 14 studies included [7, 17, 30, 31, 36, 38] 
reported quantitative or qualitative assessment of factors 
associated with compliance to RDT. Uzochokwu et  al. 
[36] reported that HWs adhered to RDT positive results, 
Table 1 Characteristics of studies included
CHW community health worker, CRT cluster randomized trial, DSV drug shop vendor, NR Not reported, RCT randomized control trial





Bisoffi [31] 2009 Burkina Faso Stable malaria 
with seasonal 
transmission
RCT Nurses NR >6 months Paracheck Pf 1050
Masanja [33] 2010 Tanzania Holoendemic Observational Clinicians 99 >5 years ParaHIT 10,650




Observational Clinicians NR All Paracheck Pf; 
ICT malaria 
Pf; SD Bioline 
Pf
1385
Manyando [38] 2014 Zambia Both low and 
high trans-
mission
Observational Clinicians NR <5 years ICT malaria Pf 1492
Chinkhumba 
[37]
2010 Malawi Stable malaria 
with sea-
sonal peak
Cross sectional Clinicians and 
nurses








2011 Nigeria High transmis-
sion
Cross sectional Clinicians, 
nurses and 
CHW
32 All ICT malaria Pf 280
Mubi [17] 2013 Tanzania Perennial 
transmission
Cross sectional Clinicians and 
nurses
20 >3 months NR 105
Shakely [18] 2013 Zanzibar Low transmis-
sion
Cross sectional Clinicians and 
nurses
33 All Paracheck Pf 3889
Batwala [30] 2011 Uganda Both low and 
high trans-
mission
CRT Clinical officers 
and nurses
30 All Paracheck Pf 44,565
Mukanga [35] 2012 Ghana, 
Uganda




Mbacham [16] 2014 Cameroon NR CRT Clinicians 198 All SD Bioline 1194
Bastiaens [39] 2011 Tanzania NR Before and 
after
Clinical officers NR Below 10 year 
olds
ICT malaria Pf; 
Paracheck Pf
501
Mbonye [7] 2015 Uganda Perennial 
transmission
CRT DSV 10 All First response 8073
Mukanga [34] 2011 Uganda High transmis-
sion
Observational CHW 14 Under 5 years NR 182
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as they believed they were more reliable in confirming a 
malaria diagnosis than presumptive diagnosis or micros-
copy. Bisoffi et al. [31] compared prescribing behaviour of 
HWs in the dry compared to rainy seasons and reported 
improved RDT negative results compliance during the 
dry season; alternative diagnoses were also made in the 
dry than the rainy season.
Manyando et al. [38] reported no association between 
prescribing of AMD to negative RDTs in children under 
five, and fever in a Zambian study. There was also no 
association between community health worker (CHW) 
or socio-demographic characteristics and classification of 
malaria based on RDT in a bivariate analysis in Uganda 
[34]. In one study though, 70 % (14/20) of the respond-
ents (HW) believed that RDTs gave inaccurate/false nega-
tive results for malaria [17]. Persistence of symptoms and 
patient pressure and demand were other factors reported 
to contribute to inappropriate AMD prescription in RDT 
Heterogeneity chi2 = 10080.46 (d.f. = 15) p = 0.00
I2 (variaon in ES aributable to heterogeneity) = 99.85%
Esmate of between-study variance Tau2 = 0.00
Test of ES = 0: z = 54.35 p = 0.00
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Fig. 4 Pooled meta-analysis of overall compliance to RDT results
Page 6 of 11Kabaghe et al. Malar J  (2016) 15:163 
negative cases [7, 17, 41]. HWs would end up prescrib-
ing AMDs in these cases to satisfy patients and maintain 
their reputation. Some HW reported that RDT negative 
patients improved when they were prescribed AMDs.
Discussion
This is the first systematic review and meta-analysis eval-
uating the proportion of health workers’ compliance with 
RDT results. Overall the compliance is fair. However, it 
also confirms that compliance to RDT negative results 
compared to positive results was generally low among 
HWs.
Diagnostic accuracy of RDT for both falciparum and 
non-falciparum malaria is high [14, 15]; sensitivity 
of up to 99.5  % and specificity of up to 90.6  % com-
pared to microscopy for P. falciparum [14]. Commu-
nity health workers can appropriately diagnose and 
treat malaria using RDT in resource limited settings 
[13]. The use of RDT to guide treatment reduces AMD 
prescription especially where health workers adhere to 
results [42].
The results show a high proportion of HWs prescribe 
appropriate treatment based on RDT results. A pro-
portion of patients still remain over- or under-treated, 
despite policy change of administering ACT to parasi-
tological confirmed cases only. Approximately 17  % of 
RDT negative patients are inappropriately prescribed 
AMDs. This estimate, extrapolated to sub-Saharan Africa 
means hundreds of thousands of patients are inappropri-
ately diagnosed for malaria and prescribed AMD drugs 
unnecessarily; unnecessary (=incorrect) AMD prescrip-
tion leads to drug wastage, unnecessary exposure to drug 
adverse effects and an increased risk of drug resistance 
development for current AMDs [43]. Where underlying 
infection is not treated, the patient’s illness prolongs and 
worsens; the patient or guardian makes multiple visits 
to seek health services, lose productivity time or income 
and leads to school absenteeism for school-going chil-
dren [21] leading to a vicious cycle of poverty and malaria 
[44].
Lower cadres of HW showed more compliance to RDT 
results than trained HWs. The high adherence is likely 
due to trust in RDT result for confirming malaria diag-
nosis. Trained HWs on the other hand may trust clinical 
symptoms and past experience more than RDT result 
[17, 45].
Factors associated with HW compliance from qualita-
tive studies include knowledge of alternative diagnosis, 
fever during the dry season and a trust in RDT result 
[30, 31, 46]. Trust may be increased by improving diag-
nostic capacity for other common febrile illnesses, and by 
developing evidence informed guidelines for treatment of 
Table 2 Appropriate treatment overall, RDT positive and RDT negative results
CHW community health worker, DSV drug shop vendors
a  Excludes missing data
b  Excludes Burkina Faso results
c  Basic training
d  Enhanced training








RCT Bisoffi Burkina Faso Nurses 60.7 97.7 19.0
Observational Masanja Tanzania Clinicians 95.9 95.8 96.0
Bottiaeua Mozambique Clinicians 93.4 95.1 92.8
Mukanga Uganda CHW 97.8 98.6 95.2
Manyando Zambia Clinicians 39.7 93.9 31.4
Cross sectional Chinkhumba Malawi Clinicians and nurses 86.9 98.0 57.9
Uzochukwu Nigeria Clinicians, nurses and CHW 60.0 100.0 25.9
Mubi Tanzania Clinicians and nurses 90.5 100.0 86.5
Shakely Zanzibar Clinicians and nurses 99.9 100.0 99.9
CRT Batwala Uganda Clinical officers and nurses 88.5 100.0 76.6
Mukangab Ghana CHW 99.5 100.0 96.7
Mukangab Uganda CHW 99.0 99.9 92.4
Mbachamc Cameroon Clinicians 56.1 72.1 48.1
Mbachamd Cameroon Clinicians 70.8 72.9 69.4
Mbonye Uganda DSV 98.8 99.0 98.5
Before and after Bastiaens Tanzania Clinical officers 90.4 100.0 90.0





Heterogeneity between groups: p = 0.000
Overall  (I^2 = 99.16%, p = 0.00);
Mukanga 2012c
Chinkhumba 2010
Subtotal  (I^2 = 54.5%, p = 0.11)
Study
CHW
































































0 .25 .5 .75 1
Proportion
RDT positive appropriately prescribe AMDs by health worker cadre
Clinicians                                    1709.23 6 0.00 99.65%
Nurses . 0 . .
Clinicians and nurses 4.39 2 0.11 54.45%
CHW                                        14.10 2 0.00 85.82%
DSV                     . 0 . .
Clinicians, nurses and CHW . 0 . .
Overall                    1789.95 15 0.00 99.16%
Random: Test for heterogeneity between sub-groups
2961.53 5 0.00
** I2 the variaon in esmate aributable to heterogeneity
Clinicians                                    Z= 16.66 p = 0.00
Nurses Z= 65.74 p = 0.00
Clinicians and nurses Z= 38.35 p = 0.00
CHW                                        Z= 38.07 p = 0.00
DSV                     Z= 204.99 p = 0.00
Clinicians, nurses and CHW Z= 28.22 p = 0.00
Overall                    Z= 37.31 p = 0.00
Fig. 5 Pooled meta-analysis of RDT positive results appropriately prescribed AMDs stratified by HW cadre
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Overall  (I^2 = 99.82%, p = 0.00);
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0 .25 .5 .75 1
Proportion
RDT negatives not prescribed AMDs by health worker cadre
Clinicians and nurses 663.27 2 0.00 99.70%
CHW                                        2.18 2 0.34 8.12%
DSV                     . 0 . .
Clinicians, nurses and CHW . 0 . .
Overall                    8554.66 15 0.00 99.82%
Random: Test for heterogeneity between sub-groups
1549 5 0.00
**I2 the variaon in esmate aributable to heterogeneity
Significance test(s) of ES=0
Clinicians                                    Z= 11.30      p = 0.00      
Nurses Z= 48.75     p = 0.00      
Clinicians and nurses Z= 4.50       p = 0.00      
CHW                                        Z= 38.38 p = 0.00      
DSV                     Z= 161.68     p = 0.00      
Clinicians, nurses and CHW Z= 10.18      p = 0.00
Overall                    Z= 14.60 p = 0.00  
Fig. 6 RDT negative results not prescribed AMD stratified by HW
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symptomatic RDT negative patients. Such guidelines may 
not apply in non-endemic areas and therefore should be 
specific to particular settings.
Knowledge of alternative diagnosis is related to the 
level of training and experience of HW [47]. HWs 
reported they likely made alternative diagnosis during 
the dry season when malaria transmission is perceived 
lower in febrile children with negative RDT result com-
pared to the wet season when transmission peaks. For 
febrile patients, alternative diagnoses were made dur-
ing the dry season while more patients were treated for 
malaria during the wet season in one study [31].
Qualitative studies report pressure on prescribers to 
satisfy patient expectations as one factor, which contrib-
utes to non-compliance of RDT negative results [44, 48]. 
Chandler et al. [49] reported patient psychology and pre-
scriber reputation as other factors influencing non-com-
pliance to of HWs to negative RDT.
Interventions to improve compliance have not been 
successful, although they led to a decrease in ACT pre-
scriptions in particular. Some HWs prescribed a non-rec-
ommended AMD in malaria negative patients [16, 50].
In cases of patients demanding AMDs, community 
sensitisation on RDTs was reported to improve patient 
satisfaction [7]. At facility level, involvement of patient in 
discussing malaria results also improved patient satisfac-
tion and reduced patient demand for AMDs [51].
Notably, few studies were available which quantified 
HW’s compliance to malaria RDT results, and even less 
studies investigated the factors contributing to compli-
ance. Understanding these factors can help design effec-
tive strategies to improve compliance of anti-malarial 
drugs. Chandler et al. [49] describe a systematic method 
of designing an intervention in Tanzania; formative 
research would be key in designing such an intervention. 
However, interventions are context-specific and may not 
be applicable to all settings, and for all HWs. It is essen-
tial to investigate factors contributing to non-compliance 
in specific cadres and settings, exploring impact in a con-
text specific manner before designing and implementing 
interventions.
Although ideal for rural areas in Africa, RDT kits 
inherently are not 100  % sensitive and specific [14, 42]. 
Clinically diagnosed malaria and positive malaria test 
may be due to other underlying causes of the fever [27]. 
Crump et  al. reported only 1.6  % of 820 patients with 
fever or history of fever actually had malaria infection in 
a Tanzanian prospective cohort study; bacterial and fun-
gal bloodstream infections were responsible for 9.8 and 
2.9 % of the fever, respectively. Resource limited settings 
lack diagnostic equipment and capacity for some dis-
eases. Diagnostic accuracy of RDTs can be affected fur-
ther by low and extremely high parasite densities [52, 53], 
patient-intrinsic factors such as rheumatoid factor posi-
tivity [54], user factors such as result interpretation and 
performance of the test, and environmental storage con-
ditions including high temperatures. It is, therefore, pos-
sible, though infrequent, for malaria-infected patients to 
have a false positive (leading to not-indicated treatment) 
or more importantly, false negative result, and hence 
miss malaria treatment if WHO malaria treatment guide-
lines are followed. A more robust and highly specific 
test may be useful to rule out malaria. False positives, 
where malaria parasitaemia is not the cause of the ill-
ness (in endemic areas) lead to neglecting of other febrile 
illnesses.
Multidisciplinary research to explore, measure and 
design interventions for increasing compliance to RDT 
results in different settings in Africa need to be con-
ducted. More innovation in diagnosis of common febrile 
illnesses in malaria endemic regions needs to be avail-
able. There is sparse data on prevalence of other non-
malaria febrile illnesses in most malaria endemic regions 
of Africa.
The meta-analysis may have overestimated compli-
ance: studies evaluating diagnostic tests generally report 
higher compliance when assessed in the study setting 
compared to a non-study setting. Most studies reported 
higher compliance to positive results compared to nega-
tive results.
A limitation for the results in the review is that risk of 
bias and publication bias were not assessed for the stud-
ies included; the quality of evidence therefore cannot be 
reported.
Conclusion
HWs compliance to RDT is fair; compliance to positive 
RDT results is generally higher compared to negative 
RDT results. Over-treatment of malaria is still a major 
problem in sub-Saharan Africa. Both HW and patient 
factors contribute to inappropriate prescribing of AMDs 
to RDT negative patients; interventions to improve com-
pliance should target both patients and HWs. Treatment 
guidelines should be developed for other causes of fever 
informed by local context and research. Multidisciplinary 
research will improve compliance of HWs to RDT results.
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